BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8022438)

  • 21. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
    Owen J; Hauth JC
    Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial.
    Yilmaz B; Kelekci S; Ertas IE; Kahyaoglu S; Ozel M; Sut N; Danisman N
    Hum Reprod; 2005 Nov; 20(11):3067-71. PubMed ID: 16037107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion.
    Eng NS; Guan AC
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):331-4. PubMed ID: 9325520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
    Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
    Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion.
    Jain JK; Mishell DR
    Am J Obstet Gynecol; 1996 Jul; 175(1):173-7. PubMed ID: 8694046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced second trimester abortion by extra-amniotic prostaglandin infusion in patients with a cesarean scar: is it safe?
    Shapira S; Goldberger S; Beyth Y; Fejgin MD
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):511-4. PubMed ID: 10376860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.
    Wong KS; Ngai CS; Wong AY; Tang LC; Ho PC
    Contraception; 1998 Oct; 58(4):207-10. PubMed ID: 9866000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
    Chaudhuri S; Banerjee PK; Mundle M; Mitra SN
    Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second trimester pregnancy termination with 400 μg vaginal misoprostol: efficacy and safety.
    Kunwar S; Saha PK; Goel P; Huria A; Tandon R; Sehgal A
    Biosci Trends; 2010 Dec; 4(6):351-4. PubMed ID: 21248435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S; Fekih M; Chaïeb A; Bibi M; Mellouli R; Khaïri H
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan.
    Kapp N; Todd CS; Yadgarova KT; Alibayeva G; Nazarova D; Loza O; Babadjanova GS
    Contraception; 2007 Dec; 76(6):461-6. PubMed ID: 18061705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Termination of second trimester pregnancy with gemeprost and misoprostol: a randomized double-blind placebo-controlled trial.
    Wong KS; Ngai CS; Chan KS; Tang LC; Ho PC
    Contraception; 1996 Jul; 54(1):23-5. PubMed ID: 8804804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Success rate of second-trimester termination of pregnancy using misoprostol.
    Prachasilpchai N; Russameecharoen K; Borriboonhirunsarn D
    J Med Assoc Thai; 2006 Aug; 89(8):1115-9. PubMed ID: 17048418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The difficult issue of second-trimester abortion.
    Rosenfield A
    N Engl J Med; 1994 Aug; 331(5):324-5. PubMed ID: 8022446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mid-trimester abortion using hypertonic saline or prostaglandin E2 gel: an analysis of efficacy and complications.
    Herabutya Y; O-Prasertsawat P
    J Med Assoc Thai; 1994 Mar; 77(3):148-52. PubMed ID: 7798849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of labour with intravaginal misoprostol and prostaglandin E2 gel: a comparative study.
    Nanda S; Singhal SR; Papneja A
    Trop Doct; 2007 Jan; 37(1):21-4. PubMed ID: 17326881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.